Analysis & Opinions
January 29, 2013
Synergy Pharmaceuticals Inc. (SGYP) recently initiated a phase Ib study on its inflammatory bowel disease (IBD) ...
January 17, 2013
Synergy Pharmaceuticals Inc.'s (SGYP) stockholders recently approved Synergy Pharma's merger with Callisto ...
January 03, 2013
Synergy Pharmaceuticals (SGYP) recently presented positive results from a phase IIb/III study on its chronic ...
December 31, 2012
Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients ...
August 28, 2012
Synergy Pharmaceuticals Inc. (SGYP) recently acquired all assets related to FV-100, an oral nucleoside analogue, ...